Michel Vounatsos
Director/Board Member chez REVVITY, INC.
Fortune : 15 M $ au 31/03/2024
Profil
Michel Vounatsos est membre du conseil d'administration de PerkinElmer, Inc. (États-Unis), de l'Institut de RYthmologie et Modélisation Cardiaque et de la Fondation n-Lorem, et directeur général et administrateur de Biogen, Inc. Dans sa carrière antérieure, il a occupé le poste de président de la ligne d'activité Soins primaires et clientèle chez Merck & Co., Inc. M. Vounatsos est titulaire d'un MBA de l'École des Hautes Études Commerciales de Paris.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOGEN INC.
0,05% | 28/04/2023 | 67 262 ( 0,05% ) | 15 M $ | 31/03/2024 |
REVVITY, INC.
0,01% | 15/05/2023 | 6 486 ( 0,01% ) | 681 030 $ | 31/03/2024 |
ZAI LAB LTD.
0,02% | 30/06/2023 | 183 320 ( 0,02% ) | 302 159 $ | 31/03/2024 |
Postes actifs de Michel Vounatsos
| Sociétés | Poste | Début |
|---|---|---|
| REVVITY, INC. | Director/Board Member | 01/03/2020 |
| ZAI LAB LIMITED | Director/Board Member | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Chief Executive Officer | 06/01/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Chief Executive Officer | - |
| L’Institut de RYthmologie et Modélisation Cardiaque | Chairman | - |
| n-Lorem Foundation | Director/Board Member | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Director/Board Member | - |
Anciens postes connus de Michel Vounatsos
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Chief Executive Officer | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Formation de Michel Vounatsos
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| REVVITY, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Health Technology |
| L’Institut de RYthmologie et Modélisation Cardiaque | |
| n-Lorem Foundation | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Health Technology |
